Skip to main content

Table 2 Correlation between circulating EOS and the T cell immunity in the mild patients

From: Circulating eosinophils associated with responsiveness to COVID-19 vaccine and the disease severity in patients with SARS-CoV-2 omicron variant infection

Mild patients

Low EOS (< 0.02 × 10^9/L) (n = 19)

Normal EOS (≥ 0.02 × 10^9/L) (n = 131)

P value

Sex

  

0.466

 Male

10 (52.63%)

81 (61.83%)

 

 Female

9 (47.37%)

50 (38.17%)

 

Age

36(31,52)

37(26,49)

0.693

WBC (10^9/L)

5.15(3.90,5.89)

5.9(4.45,6.95)

0.002

EOS (10^9/L)

0.01(0.01,0.01)

0.08(0.04,0.15)

< 0.001

Neutrophils (10^9/L)

3.34(2.48,4.07)

3.25(2.51,4.475)

0.129

Lymphocytes (10^9/L)

1.18(1.07,1.40)

1.7(1.45,2.045)

< 0.001

Monocytes (10^9/L)

0.44(0.36,0.60)

0.45(0.40,0.59)

0.376

CRP(mg/L)

1.99(0.48,11.55)

0.4(0.40,1.20)

< 0.001

D-Dimer(ug/ml)

0.14(0.14,0.14)

0.25(0.165,0.360)

0.805

CD4 (cell/ul)

595(468.00,830.00)

739 (559.18,898.50)

0.065

CD8 (cell/ul)

359(273.00,508.00)

486(373.50,618.00)

0.182

CD4/CD8

1.72(1.27, 1.94)

1.57(1.20, 2.11)

0.871

NLR

2.57(1.72, 3.80)

1.97(1.60, 2.54)

0.075

  1. Data are presented as median (IQR) or n (%). p values comparing the group of mild and severe patients are from χ² test or Mann-Whitney U test. EOS, Eosinophils. NLR, Neutrophil-to-Lymphocyte Ratio